Search Results - "Burger RA"

ASO Author Reflections: The Potential of Bidirectional Chemotherapy for Peritoneal Carcinomatosis.

Authors: Gallanis AF Perati SR Davis JL et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2026 May; Vol. 33 (5), pp. 4742-4743. Date of Electronic Publication: 2026 Feb 22.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

Association of adjuvant chemotherapy regimen with serial CA-125 kinetics (KELIM framework) and progression-free survival after cytoreductive surgery for ovarian cancer: a retrospective cohort study.

Authors: Alwazzan, Ahmad Nasief, Hisham Amjad, Razan et al.

Source: Oncologie (De Gruyter). Mar2026, Vol. 28 Issue 2, p431-439. 9p.

Validation of Folate Receptor-α Selectivity of 6 S -5-Methyltetrahydrofolate–Based Radioconjugates: A Prerequisite for Therapeutic Application?

Authors: Mapanao, Ana Katrina Hunkeler, Benjamin D. Marzaro, Giovanni et al.

Source: Journal of Nuclear Medicine. Jun2026, Vol. 67 Issue 6, p950-957. 8p.

ASO Author Reflections: Clinical Significance of Mesenteric Lymph Node Involvement in Patients with Ovarian Cancer.

Authors: Shimada Y Tanaka K Nishino K et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2021 Nov; Vol. 28 (12), pp. 7614-7615. Date of Electronic Publication: 2021 Mar 31.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

This result is not displayed to guests.
Login for full access.

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.

Authors: Thorel, Lucie Divoux, Jordane Lequesne, Justine et al.

Source: BMC Cancer. 6/7/2024, Vol. 24 Issue 1, p1-9. 9p.

The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors.

Authors: Carucci, Margherita Clamp, Andrew Zhou, Cong et al.

Source: BMC Cancer. 10/24/2024, Vol. 24 Issue 1, p1-10. 10p.

Proton beam therapy achieves excellent local control for recurrent epithelial ovarian cancer: a single-center retrospective study.

Authors: Endo, Yuta Takagawa, Yoshiaki Yoshimoto, Yuki et al.

Source: Journal of Ovarian Research. 5/27/2025, Vol. 18 Issue 1, p1-9. 9p.

Ovarian cancer and isolated cardiophrenic lymph nodes metastases: a systematic review.

Authors: Psomiadou, Victoria Fotiou, Alexandros Iavazzo, Christos

Source: Journal of the Turkish-German Gynecological Association. Mar2025, Vol. 26 Issue 1, p49-6. 6p.

GX15-070 enhances niraparib efficacy in ovarian cancer by promoting a shift in Mcl1-mediated DNA repair pathway from HR to NHEJ.

Authors: Sheng, Jia-Jia He, Yan Liu, Po-Wu et al.

Source: Journal of Translational Medicine. 11/11/2025, Vol. 23 Issue 1, p1-17. 17p.

Optimizing bevacizumab dosing in first-line ovarian cancer treatment: the PGOG-ov1 trial.

Authors: Ostrowska-Leśko, Marta Mądry, Radosław Bobiński, Marcin

Source: Trials. 9/1/2025, Vol. 26 Issue 1, p1-9. 9p.

This result is not displayed to guests.
Login for full access.

The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer.

Authors: Liu Y Yuan L Lin Z et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2025 Jan; Vol. 27 (1), pp. 340-350. Date of Electronic Publication: 2024 Jun 21.

Publication Type: Journal Article

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Soluble TREM2 engages cell-surface nucleolin to drive vascular permeability and malignant ascites in ovarian cancer.

Authors: Li Q Zhang Y Luo H et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2026 Jul; Vol. 18 (7), pp. 2667-2690. Date of Electronic Publication: 2026 May 26.

Publication Type: Journal Article

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Breast cancer prevention in patients with gBRCA-mutated ovarian cancer.

Authors: Amann N Krückel A Brückner L et al.

Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2026 Jun 21; Vol. 152 (6). Date of Electronic Publication: 2026 Jun 21.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer.

Authors: Park, Kena Kwon, Ji Young Song, Jeong Min et al.

Source: PLoS ONE. 5/28/2024, Vol. 19 Issue 5, p1-13. 13p.

Survival outcomes in IIIC cervical cancer by treatment strategies: a systematic review and meta-analysis.

Authors: Li, Yi-xiang Cao, Si-yu Fan, Yu et al.

Source: BMC Cancer. 8/20/2025, Vol. 25, p1-10. 10p.

Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial.

Authors: Yang, Xiao Dai, Yu-Hong Peng, Hui et al.

Source: BMC Cancer. 8/16/2025, Vol. 25 Issue 1, p1-14. 14p.

BRCA1 promoter methylation predicts PARPi response in ovarian cancer: insights from the KOMET study.

Authors: Nougarede, Léna Hazane-Puch, Florence de Fraipont, Florence et al.

Source: Clinical Epigenetics. 8/7/2025, Vol. 17 Issue 1, p1-11. 11p.

卵巢癌肿瘤微环境相关研究进展.

Alternate Title: Research Progress in the Tumor Microenvironment of Ovarian Cancer.

Authors: 徐梦婷 鲁娣 宋殿荣

Source: Journal of International Obstetrics & Gynecology. Apr2026, Vol. 53 Issue 2, p188-193. 6p.